Furthermore, it was unclear whether gut DGAT1 deficiency is sufficient to confer metabolic benefits, and by inference, whether gut-selective DGAT1 inhibitors would be efficacious in treating metabolic disorders. Here, DGAT1 is linked to Other metabolic disease.